The platform will undergo maintenance on Sep 14 at about 9:30 AM EST and will be unavailable for approximately 1 hour.
2012
DOI: 10.2174/092986612799080149
|View full text |Cite
|
Sign up to set email alerts
|

From Protein to Peptides: a Spectrum of Non-Hydrolytic Functions of Acetylcholinesterase

Abstract: Acetylcholinesterase (AChE), a member of the α/β-hydrolase fold superfamily of proteins, is a serine hydrolase responsible for the hydrolysis of the well studied neurotransmitter acetylcholine (ACh). However, it is becoming clear that AChE has a range of actions other than this 'classical' role. Non-classical AChE functions have been identified in apoptosis, stress-responses, neuritogenesis, and neurodegeneration. Furthermore, these non-classical roles are attributable not only to the native protein, which app… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
24
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(25 citation statements)
references
References 0 publications
1
24
0
Order By: Relevance
“…Based on the circumstantial evidence linking AChE to ALS pathogenesis we sought to test the possibility that downregulation of AChE may be beneficial in an ALS mouse model. Because AChE may have noncatalytic effects [8, 9] together with the fact that AChE inhibition with drugs such as neostigmine (Neo) raise AChE levels [10], we chose to use antisense oligonucleotides (ASO) to AChE mRNA (mEN101) as our treatment drug. To address the possibility that mEN101's effect is mediated via a non-catalytic effect (i.e., reducing AChE levels) rather than via a decrease in catalytic activity, we compared mEN101 treatment to the AChE catalytic inhibitor Neo.…”
Section: Introductionmentioning
confidence: 99%
“…Based on the circumstantial evidence linking AChE to ALS pathogenesis we sought to test the possibility that downregulation of AChE may be beneficial in an ALS mouse model. Because AChE may have noncatalytic effects [8, 9] together with the fact that AChE inhibition with drugs such as neostigmine (Neo) raise AChE levels [10], we chose to use antisense oligonucleotides (ASO) to AChE mRNA (mEN101) as our treatment drug. To address the possibility that mEN101's effect is mediated via a non-catalytic effect (i.e., reducing AChE levels) rather than via a decrease in catalytic activity, we compared mEN101 treatment to the AChE catalytic inhibitor Neo.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, in postnatal ontogenesis of hypoxic rats, the activity of acetyl-and butyrylcholinesterases (AChE and BChE) in the sensorimotor cortex had a significantly different dynamics compared to controls [68]. Apart from decreased activity of these enzymes during the first month of postnatal ontogenesis (and active formation of synaptic contacts), there were also significant changes in the distribution of the membrane-bound (involved in signal transduction) and soluble (participating in synaptogenesis [69]) forms of AChE. Moreover, with aging in rats subjected to prenatal hypoxia, there was an increase in the ratio of BChE in the total cholinesterase activity that could have a compensatory nature since this enzyme plays an important role in hydrolyzing various toxic agents, which might be produced by impaired brain tissue.…”
Section: Changes At the Molecular And Biochemical Levelsmentioning
confidence: 98%
“…In addition to the canonical role in termination of neural impulses by catalytic hydrolysis of acetylcholine, AChE in vertebrates is postulated to play many additional roles in physiology and development [35,36]. The presence of multiple genes encoding AChE in ticks may provide separation of structure and function (see Fig.…”
Section: Ticksmentioning
confidence: 99%